What Happens When You Smoke With Type 1 Diabetes?

Smoking significantly worsens nearly every aspect of type 1 diabetes, from daily blood sugar control to long-term complications affecting the kidneys, nerves, eyes, and heart. Current smokers with type 1 diabetes face a 65% higher risk of kidney disease compared to those who have never smoked, and the damage extends well beyond the kidneys. If you have type 1 diabetes and smoke, the combination accelerates the very complications that make diabetes dangerous in the first place.

How Smoking Disrupts Blood Sugar Control

Smoking makes it harder to keep blood sugar in a healthy range, even when you’re doing everything else right. In a study tracking people with type 1 diabetes over about 1.7 years, nonsmokers saw their HbA1c (a measure of average blood sugar over three months) improve by 0.4%, while smokers saw no improvement at all. Active smokers also spent less time with their blood sugar in the target range: roughly 59% of the day compared to about 71% for former smokers. That gap matters. Every percentage point of HbA1c and every hour spent above target adds cumulative stress to blood vessels, nerves, and organs.

The mechanism is straightforward. Nicotine increases insulin resistance, meaning your cells respond less effectively to the insulin you inject. The result is that you need more insulin to achieve the same effect, and blood sugar swings become harder to manage. This creates a frustrating cycle where smoking quietly undermines the daily effort of managing type 1 diabetes.

Kidney Damage

The kidneys are among the organs most vulnerable to the combination of smoking and type 1 diabetes. A meta-analysis pooling data from multiple studies found that people with type 1 diabetes who have ever smoked face a 31% higher risk of diabetic kidney disease overall. For current smokers specifically, that risk jumps to 65%.

The damage shows up in stages. Smoking is linked to a 27% increased risk of developing macroalbuminuria, a condition where significant amounts of protein leak into the urine because the kidney’s filtering units are breaking down. This is a warning sign that kidney function is declining and, without intervention, can progress toward kidney failure. Diabetes already puts strain on the tiny blood vessels in the kidneys. Smoking compounds this by further narrowing blood vessels and reducing oxygen delivery to kidney tissue.

Nerve Damage Is Substantially More Common

Diabetic neuropathy, the nerve damage that causes numbness, tingling, and pain (usually starting in the feet and hands), is far more common in smokers with type 1 diabetes. Across multiple studies, smokers with type 1 diabetes are roughly twice as likely to develop peripheral neuropathy as nonsmokers. Individual studies have found odds ranging from about 1.4 to 2.8 times the risk, depending on the population studied and how smoking was measured.

The impact on autonomic neuropathy is even more striking. Autonomic nerves control things you don’t consciously think about: heart rate, digestion, blood pressure regulation, and bladder function. One study found that current smokers with type 1 diabetes had more than six times the odds of developing cardiac autonomic neuropathy compared to those who never smoked. That form of nerve damage is particularly dangerous because it can mask the warning signs of a heart attack and cause unpredictable drops in blood pressure.

Eye Complications

Diabetic retinopathy, where high blood sugar damages the small blood vessels in the retina, is the leading cause of vision loss in people with type 1 diabetes. Smoking appears to worsen this process, though the relationship is complex. A six-year prospective study of 636 people with type 1 diabetes found significant associations between smoking and retinopathy progression, though the strength of that association varied depending on how smoking exposure and retinopathy were measured.

What’s clear is that smoking constricts blood vessels and reduces oxygen supply to the retina, which is already under stress from diabetes-related damage. Even if the statistical picture is less clean-cut than it is for kidney or nerve damage, the biological logic is hard to argue with: anything that further impairs blood flow to an oxygen-hungry tissue like the retina is going to make things worse.

Heart and Circulation Risks

Type 1 diabetes already raises cardiovascular risk substantially. Smoking amplifies that risk in ways that are well documented across diabetes populations. In people with diabetes and high blood pressure, smoking nearly doubles the risk of coronary heart disease (a hazard ratio of 1.87). While much of the cardiovascular research combines type 1 and type 2 diabetes populations, the underlying vascular damage from smoking, including arterial stiffening, increased inflammation, and faster plaque buildup, applies regardless of diabetes type.

Poor circulation also has consequences you can see and feel. Smoking reduces blood flow to the extremities, which in combination with diabetic neuropathy creates a perfect storm for foot problems. Smokers with diabetes undergo amputations at a younger age than nonsmokers, and smoking is an independent risk factor for diabetic foot amputation.

Wound Healing and Foot Health

If you have type 1 diabetes, even a small cut or blister on your foot can become a serious problem. Smoking makes this worse by impairing the body’s ability to heal. Reduced blood flow means less oxygen and fewer immune cells reach the wound site, slowing recovery and increasing infection risk.

The data on smoking cessation and wound outcomes is encouraging, though. Quitting smoking for more than three weeks before a surgical procedure has been shown to reduce postoperative complications from 52% to 18%. That dramatic improvement illustrates just how directly smoking interferes with tissue repair. For someone with type 1 diabetes who already faces elevated wound healing challenges, removing smoking from the equation makes a meaningful difference.

What Happens When You Quit

The damage from smoking is not permanent, at least not all of it. Former smokers with type 1 diabetes show glycemic control that closely resembles that of people who never smoked. In one study, former smokers spent about 71% of the day in their target blood sugar range and had an average HbA1c of 7.1%, compared to 59% time in range and an HbA1c of 7.5% for active smokers. Former smokers were also more than twice as likely to achieve optimal glycemic control (43% vs. 19%).

These findings support the idea that quitting smoking at any point can reverse at least some of its negative effects on blood sugar management. The average time since quitting in the former smoker group was about 14 years, so the data doesn’t tell us exactly how quickly improvements begin. But the trajectory is clear: the body’s response to insulin improves once smoking stops, and blood sugar becomes easier to manage. The American Diabetes Association now recommends that clinicians ask about tobacco use, including electronic cigarettes, as a routine part of diabetes care and make appropriate referrals for cessation support. For younger patients, guidelines specifically encourage preventing smoking initiation and supporting cessation in those who have already started.